Insights and Stories on Approval

Jul. 15, 2020 at 6:50 pm CDT

Washington | Reuters — Elanco Animal Health has won U.S. antitrust approval to buy Bayer’s animal health business on condition that it sell assets to treat three ailments, two in dogs and one in cattle, the Federal Trade Commission said on Wednesday. The deal was valued at $7.6 billion when […]

By Reuters

Apr. 25, 2019 at 4:17 pm CDT

Brasilia | Reuters –– Brazil Foreign Minister Ernesto Araujo said on Thursday that the country must work with China to reduce non-tariff barriers to agriculture trade, including improving the process for genetically modified goods. Brazil is the world’s largest exporter of soybeans, the vast majority of which are genetically modified […]

By Jake Spring

Jun. 4, 2018 at 1:35 pm CDT

Frankfurt | Reuters — Germany’s Bayer will wrap up the US$63 billion takeover of Monsanto on Thursday and also retire the U.S. seed and chemical firm’s 117-year-old name. The German drugmaker had received all required approvals from regulatory authorities, it said in a statement on Monday. “Bayer will remain the […]

By Ludwig Burger

Feb. 7, 2018 at 4:44 pm CST

Brasilia | Reuters — Brazilian antitrust agency Cade on Wednesday approved Bayer’s proposed takeover of U.S. seeds company Monsanto without requiring further asset sales beyond a global proposal announced last October. Cade’s commissioners voted 4-2 in favour of the tie-up under an agreement, negotiated between the companies and global antitrust […]

By Bruno Federowski, Leonardo Goy

Mar. 27, 2017 at 1:45 pm CDT

Reuters — Dow Chemical and DuPont won the blessing of the European Union for their US$130 billion merger on Monday by agreeing to sell substantial assets including key research and development activities. The European Commission had been concerned that the merger of two of the biggest and oldest U.S. chemical […]

By Foo Yun Chee